Atom | NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

Funder: National Institutes of Health

Funding Amounts: UG3 phase: up to $250,000 direct costs (1 year); UH3 phase: no set limit, up to 5 years; total project period up to 6 years

Summary: Supports implementation of investigator-initiated, single or multi-site interventional clinical trials (all phases) in NIAMS mission areas using a milestone-driven UG3/UH3 cooperative agreement.

Key Information: Application review uses the new NIH simplified review framework; consultation with NIAMS staff before applying is strongly encouraged.

NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

Sign in to see full grant listing